# Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

> **NCT04784091** · PHASE3 · COMPLETED · sponsor: **Tarsus Pharmaceuticals, Inc.** · enrollment: 412 (actual)

## Conditions studied

- Blepharitis

## Interventions

- **DRUG:** TP-03
- **DRUG:** TP-03 Vehicle

## Key facts

- **NCT ID:** NCT04784091
- **Lead sponsor:** Tarsus Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-29
- **Primary completion:** 2022-05-09
- **Final completion:** 2022-05-09
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2023-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04784091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04784091, "Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04784091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*